Matthew Dirckx, VP of Engineering
Professional Overview
Matthew Dirckx is an experienced engineering leader with a strong background in the biotech and medical device industries. As the VP of Engineering at Vaxess Technologies, he oversees the company's R&D efforts, driving innovation and optimizing processes to deliver cutting-edge drug delivery solutions. Dirckx's expertise spans microfluidics, nanotechnology, and process development, making him a valuable asset in advancing Vaxess' mission to revolutionize the way vaccines and therapeutics are administered.
Experience Summary
Current Role
As the VP of Engineering at Vaxess Technologies, Dirckx leads a team of talented engineers in developing novel transdermal drug delivery platforms. In this role, he is responsible for managing the engineering department, setting strategic priorities, and ensuring the successful execution of complex R&D projects. Under his guidance, Vaxess has made significant strides in advancing its core technology, resulting in multiple patent filings and the successful completion of preclinical trials.
Career Progression
Prior to his current position, Dirckx held various engineering roles at Vaxess Technologies, including Director of Engineering and Director of Process Development. During his tenure, he played a pivotal role in scaling the company's manufacturing capabilities and optimizing production workflows. Before joining Vaxess, Dirckx co-founded Simprint Nanotechnologies, a startup focused on developing innovative microfluidic technologies. He also gained extensive experience in the medical device industry, serving as a Microfluidics Engineer and Project Leader at OPKO Diagnostics, LLC.
Dirckx's academic background includes a Ph.D. in Mechanical Engineering from the Massachusetts Institute of Technology, where he conducted groundbreaking research in the field of microfluidics. His postdoctoral work at MIT further honed his expertise in advanced manufacturing techniques and materials science.
Areas of Expertise
- Microfluidics and nanoengineering
- Biomedical and pharmaceutical process development
- Transdermal drug delivery systems
- Innovative manufacturing techniques
- R&D project management and team leadership
- Intellectual property strategy and portfolio development
Professional Impact
Under Dirckx's leadership, Vaxess Technologies has made significant advancements in its proprietary FABRIC™ platform, which utilizes silk-based microneedle arrays to enable efficient transdermal delivery of vaccines and therapeutics. His engineering expertise and strategic vision have been instrumental in securing multiple grants and partnerships, positioning Vaxess as a leading innovator in the field of drug delivery.
Dirckx's contributions extend beyond Vaxess, as he actively participates in industry conferences and serves on advisory boards, sharing his knowledge and insights to drive progress in the biomedical engineering community.
Conclusion
With his extensive experience, technical prowess, and proven track record of successful R&D program management, Matthew Dirckx is a highly valuable asset to Vaxess Technologies. As the company continues to push the boundaries of drug delivery technology, Dirckx's leadership and engineering excellence will play a crucial role in translating innovative ideas into tangible solutions that improve patient outcomes.
